Skip to content

Impact of Coffeeberry Extract on Skill Performance During Simulated Match Play in Academy Football Players

Impact of Coffeeberry Extract on Skill Performance During Simulated Match Play in Academy Football Players

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05547204
Enrollment
15
Registered
2022-09-21
Start date
2022-06-30
Completion date
2022-12-04
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coffeeberry Effects, Skill Performance, Soccer Performance

Keywords

coffeeberry, caffeine, polyphenols, chlorogenic acid, exercise, soccer, football, skill, performance

Brief summary

This study of soccer skill performance has three objectives: 1. Compare effects of coffeeberry (300mg) and placebo ingestion on dribbling speed and precision, passing speed and accuracy, and sprint speed during a full simulated soccer match. 2. Compare effects of coffeeberry (300mg) and placebo ingestion on subjective measures (mental / physical energy and activation-deactivation (feelings or mood) during a full simulated soccer match. 3. Compare effects of coffeeberry (300mg) and placebo ingestion on chlorogenic acid (CGA) and caffeine metabolites in the blood 1-hour post ingestion, and other blood metabolites (glucose/lactate) throughout the simulated soccer match.

Interventions

Free from added carbohydrates (contain 1g CHO only) and electrolytes are absent.

Sponsors

PepsiCo Global R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 28 Years
Healthy volunteers
Yes

Inclusion criteria

* Provide valid informed consent prior to any study procedure * Male soccer players age 16 to 28 years. * \>= 5-year soccer playing experience * \>= 1-year regularly soccer training * Free of injuries * Willing to avoid alcohol in the 48-h period prior to all visits * Willing to avoid caffeinated products and apples, berries/cherries for 24-h prior to all visits * Willing to record food intake over the 48-h period prior to the first trial and replicate for second trial * Willing to abstain from strenuous physical activity for 24-h before all visits

Exclusion criteria

* Smoking * Cardiovascular diseases * Diabetes or other metabolic disease • Hypertension (\>140/\>90 mm Hg) * Presence of injuries * Major illnesses or surgery in prior 90 days * Participation in another clinical trial in the past month

Design outcomes

Primary

MeasureTime frameDescription
Dribbling speedChange from pre-dose baseline through end of match 3.5 hours post consumption at multiple intervals each half of matchm/sec, increase would be better. Simulated soccer match in an indoor gym with pre-set targets.
Dribbling precisionChange from pre-dose baseline through end of match 3.5 hours post consumption at multiple intervals each half of matchMeters, more accuracy would be better. Simulated soccer match in an indoor gym with pre-set targets.
Passing accuracyChange from pre-dose baseline through end of match 3.5 hours post consumption at multiple intervals each half of match.1 to 10 scale, a higher score would be better. Simulated soccer match in an indoor gym with pre-set targets.
Passing speedChange from pre-dose baseline through end of match 3.5 hours post consumption at multiple intervals each half of matchkm/h, increased passing speed would be better. Simulated soccer match in an indoor gym with pre-set targets.
Sprint speed.Change from pre-dose baseline through end of match 3.5 hours post consumption at multiple intervals each half of matchm/sec, increased sprint speed would be better. In indoor gym with marked course.

Secondary

MeasureTime frameDescription
Activation-deactivation (feelings or mood)Pre-dose baseline, 60 minutes post-dose, half-time, and end of match (3.5 hours)Checklist of 20 feelings using a 4 point scale from definitely do feel to definitely don't feel. More relaxed feelings or in a better mood would be better.
Mental energyPre-dose baseline, 60 minutes post-dose, half-time, and end of match (3.5 hours)Visual Analog Scale (VAS), vertical marking on 100 mm horizontal line. Higher energy would be better
Physical energyPre-dose baseline, 60 minutes post-dose, half-time, and end of match (3.5 hours)Visual Analog Scale (VAS), vertical marking on 100 mm horizontal line. Higher energy would be better
Blood analyte: Chlorogenic acid (CGA)Pre-dose baseline, 60 minutes post-dose, half-time, and end of match (3.5 hours)mmol/L to evaluate primary outcomes. n.a. for placebo. Capillary blood draw for frozen plasma analysis
Heart rateContinuous from pre-dose baseline through end of match (3.5 hours)By electronic reading. Lower would be better.
Hydration statusPre-dose baseline and end of match (3.5 hours)Urine osmolality in mOsm/kg change in concentration pre- vs. post-exercise
Gut comfortPre-dose baseline, 60 minutes post-dose, half-time, and end of match (3.5 hours)Visual Analog Scale (VAS), vertical marking on 100 mm horizontal line. No or less nausea, fullness or bloating would be better
Blood analyte: Caffeine metabolitesPre-dose baseline, 60 minutes post-dose, half-time, and end of match (3.5 hours)ug/ml, to evaluate primary outcomes. n.a. for placebo. Capillary blood draw for frozen plasma analysis
Blood analyte: GlucosePre-dose baseline, 60 minutes post-dose, half-time, and end of match (3.5 hours)mmol/L, more regulated would be better. Capillary blood draw for frozen plasma analysis
Blood analyte: LactatePre-dose baseline, 60 minutes post-dose, half-time, and end of match (3.5 hours)mmol/L, lower (delayed rise) would be better. Capillary blood draw for frozen plasma analysis
Rating of perceived exertion (RPE)Half-time and end of match (3.5 hours)By Borg scale, rated 6 to 20, very very light to very very hard. Lower values would be better

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026